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Behaviour of tolamolol (-bIocking agent) in man: Influence of
renal insufficiency. L. Balant, A. Gorgia, J.-M. Tschopp, A. Marmy
andJ. Febre. Policlinique Universitaire de Mèdecine, Genève, Swit-
zerland. Tolamolol (100mg) was given orally to six normal volun-
teers (NORM) and to six patients with renal insufficiency (RI),
whose GFR ranged from 40 to 5 mI/mm. Plasma concentrations of
tolamolol and hydroxy-tolamolol (main metabolite) were mea-
sured from 0 to 24 hr. Cardiac frequency and blood pressure were
monitored under clinostatism and during isoprenaline stimulation
tests. Tolamolol was well absorbed from the gastrointestinal tract
but underwent extensive hepatic first-pass metabolism. In NORM,
maximal tolamolol plasma concentrations (± SD) (247 75
ng/ml) were reached at 1.5 hr. In RI, the maximal concentrations
(460 300 ng/ml) were reached at 2 hr. Maximal hydroxy-tolamo-
lol concentrations occurred 15 mm later (NORM = 159 53
ng/ml; RI = 141 + 31 ng/ml). The plasma half-life of tolamolol
was longer (P < 0.05) in RI (4.8 2 hr) than in NORM (2.8 0.8
hr), whereas no significant difference could be observed for the
of hydroxy-tolamolol (NORM = 2.3 hr; RI = 3.6 hr) with the
exception of the patient with a GFR of 5 mI/mm (t = 11.5 hr). In
RI, there was no correlation between GFR and the observed
deviations from NORM, but the most striking difference in RI as
compared to NORM was the great variability of all the measured
parameters. This difference in variability was also observed for the
biological effect of the drug, the action of which was much more
sustained in RI than in NORM. The fact that in RI the gastrointes-
tinal absorption seems delayed, the distribution of the drug dis-
turbed, and the elimination from plasma (a liver-dependent meta-
bolic process) reduced, confirms that RI can disturb the
pharmacokinetics by processes other than merely reducing renal
excretion.
Interrelations between blood pressure response to diuretics and
circulatory volume, plasma renin, and urinary catecholamines in
essential hypertension. C. Beretta-Piccoli, P. Weidmann, R. de
Chatel, W. A. Ziegler, and F. C. Reubi. Medizinische Poliklinik,
Universitaet Bern, Switzerland. The blood pressure-lowering effects
of certain diuretics have been shown to be greater in low-renin than
in normal or high-renin essential hypertension. The mechanisms
underlying this, however, have not been clarified. The effects of six
weeks of treatment with the mineralocorticoid-antagonist, spi-
ronolactone (400 mg/day), or with the loop-diuretic, mefruside
(mean maximal dose of 110 mg/day), were studied in 35 patients
with benign essential hypertension. Untreated patients with a low
plasma renin activity (PRA) (radioimmunoassay) had lower (P <
0.05) urinary excretion rates of adrenalin or total catecholamines
than patients with normal or high PRA; circulatory volume (1311.
human serum albumin) was comparable in low and normal PRA
subgroups and tended to be decreased in high PRA patients.
Compared with mefruside (N = 16), spironolactone (N 19)
caused greater reductions in mean supine (14 vs. 4%; P < 0.05) or
upright blood pressure(17 vs. 6%; P <0.05), body wt(3.2 vs. 2.3%;
NS), and plasma (9 vs. 2%; NS) or blood volumes (8 vs. 0%; P <
0.05), and it induced a more pronounced increase in mean PRA
(650 vs. 283%; P < 0.025). With both diuretics, the changes in
blood pressure correlated inversely with pre-therapeutic PRA ( r =
—0.62 and —0.52, respectively; P < 0.005), but not with treatment-
72
induced variations in blood volume, PRA, or the blood volume-
renin product. These results suggest: 1) the different antihyperten-
sive efficacy of spironolactone and mefruside may be related to
their different effects on blood volume; 2) patients with low-renin
hypertension demonstrated an increased blood pressure-sensitivity
to both diuretics, and this did not appear to be volume or renin-
dependent; 3) since the low urinary catecholamine excretion rates
in hyporeninemic essential hypertension suggests diminished ad.
renergic activity, the marked blood pressure-sensitivity to diuretic
treatment in such patients may be due to impaired compensatory
sympathetic activation in response to diuretic-induced volume-
depletion.
Femoralhead necrosis (FHN) after kidney allotransplantation. U.
Bins wanger, A. Schreiber, F. Largiadèr, J. Fischer. Departementfir
innere Medizin, Nephrologische Station, Orthopâdische Klinik
Balgrist, Chirurgie A, Universitat Zirich, Switzerland. Twenty-
three out of 230 recipients of kidney allotransplants developed
necrosis of the femoral head; 12 patients were affected unilaterally;
11 bilaterally; 3 cases showed, in addition, necroses at other ske-
letal sites. A retrospective analysis of frozen serum samples of the
patients with FHN, compared to age and sex-matched controls
studied after the same time interval after transplantation, revealed
the following (mean parathyroid hormone (PTH, normal
<0.6 ng/ml) before transplantation (N 5)42.8 18.6 vs. 9.7
2.7 (NS); at 3 months (N = 5), 2.3 0.6 vs. 1.1 0.2 (NS); at 6
months (N = 13), 1.2 0.2 vs. 1.1 0.2 (NS). Serum calcium,
phosphorus, and creatinine concentration were not different be-
tween groups and not correlated to PTH. At I to II years after
transplantation, the calcium content of forearm (g/cm2) (N = 9)
was 0.778 0.054 vs. 0.767 0.068 (NS), serum cholesterol, 248
18 vs. 204 14 (NS), triglycerides, 204 + 61 vs. 165 20 (NS).
The dose of prednisone during year after transplantation was
8.54 + l.O0gvs.9.77 I.47(NS).Thecortisonetreatmentand/or
the persisting hyperparathyroidism might contribute to the devel-
opment of bone necroses. Eleven patients underwent total hip
replacement, 4 bilaterally, because of drug resistant pain. Clinical
results are excellent, the prosthesis stable, and the kidney function
unaltered for observation up to four years.
Fluoride metabolism in azotemic rats. U. Binswanger, A. Seiden-
berg, W. Grubenmann, U. Flueler, B. A mey. Departemens flr Innere
Medizin, Nephrologische Station. Universitât Zurich, Switzerland.
Three groups of 5/6 nephrectomized (nx) and sham operated (sh)
rats weighing 150 g were fed a diet containing 7 ppm of fluoride
(F); the F content of the drinking water was 1.5, 3, and 30 ppm.
After three weeks the following data were obtained (nx vs. sh,
means + SD): serum-F, ppm = 0,027 0.005 vs. 0.015 0.005;
0.036 + 0.006 vs. 0.029 0.006; 0.186 0.093 vs. 0.083 + 0.032. F
inashoffemur,ppm= l313+196vs.93±28;1l05±258vs.4l9
54; 3290 649 vs. 2222 + 402. Bone ash, % of fat free dry wt =
45.5 + 2.0 vs. 45.6 + 2.2; 45.8 + 2.4 vs. 45,9 2.3; 44.8 2.8 vs.
46. 1 + 2.9. Conclusions.' Renal insufficiency increases serum F and
bone F significantly at the three levels of F uptake tested. Serum F
concentrations at 1.5 and 30 ppm F-content of the drinking water
are comparable to those observed in normals or patients with
advanced renal failure and during F-treatment for osteoporosis,
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respectively. As far as the short experimental period is com-
pensated by rapid bone turnover of the growing animal, one can
conclude that in the range tested the bone quality, as judged by its
ash content, is not altered by F accummulation during renal in-
sufficiency. Functional properties of this bone are currently under
study.
Myoinosltol: A uremic neurotoxin? A. Blumb erg. E. Esslen,
W. Bflrgi. Medizinische Klinik and Zentrallabor, Kantonsspital,
Aarau, Switzerland. Myoinositol (Myo), which is retained in renal
insufficiency, has been claimed to be an important factor in the
genesis of uremic neuropathy. We therefore determined plasma (P)
and spinal fluid (SF) Myo concentrations and correlated them with
nerve conduction velocity (NCV) and EEG changes. In 28 pa-
tients, predialysis P Myo was significantly elevated (10.8 2.5 vs.
0.75 0.15 mg/dl in normals) and was weakly correlated with P
creatinine (r = 0.42, P < 0.05). Dialysis reduced P Myo to 3.5
1.1 mg/dl. In 16 more extensively studied patients, SF Myo was
markedly elevated (9.4 2.3 vs. 2.7 + 0.7 mg/dl in normals, P <
0.001). NCV was reduced in 15, and EEG was abnormal in 12 of 16
patients studied. Neither SF nor P Myo, however, showed any
correlation with NCV or EEG changes (r = 0.05 to 0.20, NS). In
the patients studied, no indication was found that myoinositol is a
toxin causing uremic neuropathy.
Role of 1,25-dihydroxyvitamin D3 in the regulation of the tubular
transport of inorganic phosphate (P1). f-P. Bonjour, C. Preston, and
H. Fleisch. Pathophysiologisches Institut, Univeritit Bern, Bern,
Switzerland. Thyroparathyroidectomy (TPTX) leads to a change in
the tubular capacity to transport P1 and also to a decrease in the
renal conversion of 25-hydroxyvitamin D (25-OHD3) into 1,25-
dihydroxyvitamin D3 (l,25-(OH)2D3). We have examined whether
l,25-(OH)2D3, when given in small doses (2 X 13 pmoles/day i.p.
for 7 days), which just corrects the low intestinal calcium absorp-
tion of TPTX rats, would influence the renal handling of P1 in these
animals. The results show that l,25-(OH)2D3 given to TPTX rats
abolishes the difference in the renal handling of P1 between TPTX
and sham-operated rats fed a 1.2 g/lOO ml of phosphorus diet. The
effect of l,25-(OH)2D3 on the renal handling of P1 was not asso-
ciated with changes in the renal handling of sodium, calcium,
urinary excretion of cyclic AMP, or urinary pH. Furthermore,
although l,25-(OH)2D3 given to TPTX rats is not the factor re-
sponsible for the tubular adaptation to changes in dietary P1, it
fully restores the ability of the tubular P1 transport system to adjust
to large variations in the P1 intake. In conclusion, it appears that
the chronic change in the tubular capacity to transport P1 following
thyroparathyroidectomy could be due to the decrease in the forma-
tion of l,25-(OH)2D3.
Effect of /3-blocking agents and angiotensin II on isoproterenol-
stimulated renin release from rat kidney slices. A. Capponi, M.
Gourjon, and M. B. Vallotton. Division d'Endocrinologie, Dêparte-
ment de Médecine, Facultè de Médecine, Université de Genève,
Genève, Switzerland. The mechanism of the hypotensive action of
13-blocking agents is not completely understood. Previous results
from this laboratory showed that renin release in vitro can be
stimulated by /3-adrenergic agents. In this study, we investigated
the response of isoproterenol-stimulated renin release, to 15 /3-
blocking drugs and to angiotensin II. Three different responses to
graded doses of various i3-blocking agents on rev in release stimu-
lated by a fixed dose of isoproterenol (lO-6M) were observed: I)
Metoprolol, acebutolol, and labetalol did not reduce stimulated
renin release, while bufuralol and pindolol had a slightly inhibiting
effect only at l05M. 2) dl-, l-propranolol, sotalol, and alprenolol
inhibited quite effectively isoproterenol stimulation to control val-
ues at doses between 5 X lO-° and l0-°M. At higher doses, how-
ever, stimulation of renin release reappeared. 3) Oxprenolol, prac-
tolol, nadolol, timolol, and atenolol exerted a dose-related
inhibiting effect at doses ranging from l0_8 to 10M. None of these
agents inhibited basal renin release, while those of group 2 signifi-
cantly stimulated it. Basal renin release was significantly inhibited
by lO-'M angiotensin II, which abolished, also in a dose-related
manner, the stimulation of renin release by isoproterenol. Sar1-ala'
-angiotensin II prevented the inhibition induced by angiotensin II,
but did not affect either basal or isoproterenol-stimulated renin
release, These results demonstrate that i3-blocking drugs display
three patterns of responses on isoproterenol-stimulated renin re-
lease in vitro, which cannot be completely explained by their
known pharmacologic properties. Moreover, angiotensin II inhibi-
tion of renin release appears to be functionally related to adrener-
gic pathways.
Idiopathic mixed cryoglobulinemia and glomerulonephritis: Dis-
cussion of one case. J. A. Cerutti and A. Edward. Ospedale Civico,
Lugano, Switzerland. The clinical, biochemical, and histological
manifestations characterizing idiopathic mixed cryoglobulinemia
were studied in one patient presenting with symptoms of purpura,
arthralgia, asthenia, and cryoglobulinemia complicated by pro-
liferative endocapillary glomerulonephritis. The purified cryopre-
cipitate was subjected to immunochemical analysis and revealed a
circulating antigen-antibody complex, composed of IgG-IgM im-
munoglobulins. The monoclonal function of the anti-IgU antibody
of the 1gM fraction was confirmed in the presence of human anti-
globulin (positive latex and Waaler-Rose reactions). The IgG-IgM
complex formation was associated with a significant reduction of
serum complement factors, which, however, could not be detected
in the cryoprecipitate. The presence of the IgM-IgG components as
dense granular deposits in endomembranous and mesangial struc-
tures of the glomeruli, in association with C3 complement factor,
also suggested immune complex properties of the cryoprecipitate,
which might be involved in the pathogenesis of the glomeruloneph-
ntis. In contrast, purpura in the lower limb seemed to be associated
with intravascular precipitation of the complex IgM-IgG by mech-
anisms involving orthostatism and local reduction of blood flow
rather than immunological phenomena. Deposits of IgG-IgM
without complement were found in cutaneous capillaries under
optical and immunofluorescent microscopic examination. The
walls of the vessels did not show inflammatory lesions.
Electrolyte content and organic ion transport in fetal mouse kid-
neys. J. Diezi, P. Michoud-Hausel, N. Buxcel. Institut de Pharma-
cologie de l'Universitè, Lausanne, Switzerland. Sodium (Na) and
potassium (K) content, as well as extracellular space, were mea-
sured in developing metanephric kidneys from mouse embryos
from day 12 in utero onwards. '4C-inulin distribution space was
similar at all ages, averaging 26% of wet wt. Tissue Na content was
similar in embryonic kidneys independently of gestational age and
adult renal cortex (0.3 MEq/mg of dry wt). K content was higher in
fetal kidneys than in adult cortex but decreased progressively until
birth. At all ages, tissue K content decreased and Na content
increased after incubation in ice-cold saline medium without K, or
in medium containing ouabain (l03M). These changes were qual-
itatively similar to those observed in adult cortex. Organic ion
transport in fetal kidneys was estinsated by measuring steady state
tissue-to-medium concentration ratios of"C-para-aminohippurate
(PAH) at various stages of development. Until day 15 in utero, the
ratios were lower than unity, while a steep increase of PAH uptake
occurred between day 16 and 18 in utero. Before birth, tissue-to-
medium ratio was 4.8, as compared to 7.2 in adult cortex. A much
smaller increase of organic cation transport ("C-tetra-ethyl-ammo-
nium) was observed during growth in utero.
Immune-complex glomerulonephritis associated with hepatitis B
virus infection. H. Favre, B. J. Hirschel, L. N. Benusiglio, F. Chat-
elanat, and A. Cruchaud. Dept. dv Médecine, Divisions de Nèphro-
logie et d'Im,nunologie, Hbpital Cantonal, Genève, Switzerland.
Some cases of glomerulonephritis (GN) have been ascribed to the
deposition of hepatitis B surface antigen (HBAg) antibody com-
plexes on the glomerular basement membrane (GBM). A 45-yr-old
patient presented with nephrotic syndrome seven years after acute
hepatitis. At that time, the patient was found to be HBAg positive.
The histologic diagnosis of the nephropathy was membranoproli-
ferative glomerulonephritis with deposits of immunoglobulins
complement and HBAg. Circulating immune complexes have
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been detected in the serum. Total hemolytic complement, C3 and
C4 were moderately lowered; C3d was elevated while evidence for
activation of the alternate pathway was lacking. Six months later,
HB.Ag was no longer detectable in the glomeruli, although the
entire clinical and biological picture was unchanged. We conclude
that this ON is probably due to a HB-associated antigen, but not
necessarely due to HB.Ag.
Treatment of Bartter's syndrome. E. D. Flory, L. Faure, M. B.
Vallotton, and F. Dray. Hbpital Cantonal, Genève, Switzerland, and
Institut Pasteur, Paris, France. In the past, combined therapy of
Bartter's syndrome with potassium supplements and potassium-
sparing diuretics resulted only in correction of the hypokaliema.
Propranolol was later introduced to decrease renin hypersecretion.
Indomethacin was recently proposed as a more effective and sim-
pler form of treatment. Indomethacin was claimed to lower renin
indirectly by its known inhibiting effect on prostaglandin synthet-
ase. We report two adult patients with Bartter's syhdrome in whom
standard therapy was successfully changed to indomethacin treat-
ment alone. Before any treatment, both patients were severely
hypokaliemic with plasma renin activity (PRA) elevated to 45 and
14 ng/ml/hr respectively, and urinary aldosterone (A) to 6 and 13
Lg/24 hr, respectively. Daily treatment with 96 mEq of potassium,
240 mg of propranolol, and 300 mg of triamserene in case 1 or 100
ing of spironolactone in case 2 resulted in marked clinical improve-
ment. Serum potassium rose from 1.0 and 1.8 to 4.0 and 3.3
mEq/liter, respectively. Concomitantly, PRA fell to 15.3 in case I
and rose to 23 ng/ml/hr in case 2, while A rose in both cases to 30
and 79 tg/24 hr, respectively. After interrupting this treatment, all
characteristic abnormalities reappeared. Indomethacin treatment
(150 mg/day) was then instituted. This resulted in correction of
hypokalemia and normalization of A (4.6 and 5.3 iig/24hr) and a
dramatic fall of PRA to 1.2 and 4.0 ng/ml/hr, respectively.
Urinary prostaglandins (ng/24 hr), E2 (PGE2), and F2a (PGFa)
were measured by specific radioimmunoassays before and after
indomethacin:
Patient no.
PG E2
before after 3 days 18 days
I 365 52 27
2 416 126
after 5days
67
Controls 134—367 33—154
Patient no,
PGF2a
before after 3 days 18 days
1 1143 265 193
2 1543 832
after 5 days
269
Controls 685—1481 379—781
Conclusion. Indomethacin given alone in these two cases of Bart-
ter's syndrome corrected all the biochemical and clinical abnor-
malities. Urinary prostaglandins, not present in excess at the onset,
were effectively suppressed by indomethacin. The effect of in-
domethacin, however, was transitory in patient 2 with escape oc-
curring after two months, while patient 1 is still controlled after ten
months of therapy.
Analgesic dependence in patients with kidney transplants formerly
suffering from analgesic nephropathy. J. Frei, U. C. Dubach and
G. Thiel. Med. Unfv-Poliklinik und Nephrologische Ab:., Dept. fur
Innere Medizin, Kantonsspital, Base!, Switzerland, From 1967 to
1976, 102 patients received kidney transplants. Twenty-four admit-
ted abuse of analgesics containing phenacetin. At the time of the
study, 12 were still alive with a functioning transplant. Within two
to eight months, on the occasion of routine check-ups, five 24-hr
urine samples were tested for N-acetyl-paraamino-phenol (NA-
PAP), the main metabolite of phenacetin. Out of the eight females
and four males tested, five females were still ingesting analgesics
containing phenacetin. Only in one case could continuous anal-
gesic dependence be assured; the other four showed a varied pat-
tern of excretion of NAPAP in the urine, suggesting occasional
intake of analgesics containing phenacetin. Determination of
urinary NAPAP excretion is advocated in the routine check-up of
transplanted patients who previously abused analgesics.
Hemodynamic and natriuretic effects of bumetanide and furose-
mide in the cat. P. A. Friedman and F. Roch-Ramel. Institut de
Pharmacologie, Lausanne, Switzerland. The relationship between
renal hemodynamic effects and the natriuretic action of bumeta-
nick (B) and furosemide (F) was studied in the cat whose renal
venous anatomy permits determination of filtration fraction (FF)
and para-aminohippuric acid (PAH) extraction (EXPAH) in the
superficial and deep regions. Catheters were placed in superficial
and deep renal veins; renal blood flow (RBF) was measured with
an electromagnetic flowmeter or with PAH. Glomerular filtration
rate (GFR) was estimated from the inulin clearance and superficial
and deep FF from inulin extractions. Urine losses were continu-
ously replaced. Furosemide (0.04 to 5.0 mg/kg, iv., single injec-
tions) effects increased with increasing doses up to a maximal
fractional sodium (FE) and water (V/GFR) excretion of 24%.
GFR remained constant. Superficial single nephron GFR (prox-
imal determination), at the highest dose of F, was unchanged (10.7
1.4 nI/mm, control; 11.4 + 2.0 nI/mm, 5.0 mg/kg, F). REF
increased with increasing doses of F to a maximum 145% of
control. Superficial and deep FF and ExPAI decreased equally in
the two regions. Bumetanide (0.001 to 0.14 mg/kg) induced a
maximal FENa and V/GFR of 24% at a dose of 0.14 mg/kg. The
potency of B, thus, was 40 times that of F. No change occurred in
RBF, FF or ExPAH. At a higher dose of 0.69 mg/kg, B raised REF
and depressed in parallel FF and EXPM but not further increase
FENa. GFR remained constant. Thus, maximally effective doses of
B Ofl FEN4 did not affect RBF. Neither B nor F induced a redistri-
bution of RBF or GFR nor a change of GFR.
Pressure diuresis in isolated kidneys of DahI's hypertension-prone
rats. E. Girardin, M. Touabi, J. lwai, A. Grandchamp. and A. F.
Muller, with the technical assistance of A. Courtieu, and N. Mon-
tandon. Laboratoire de néphrologie experimentale, Département de
médecine, Universjté de Genève. Switzerland and Medical Depart-
ment, Brookhaven National Laboratory N.Y., USA. From chronic
excess salt-feeding, DahI's sensitive (S) rats develop hypertension,
whereas resistant (R) rats remain normotensive. Graft experiments
have shown that the renal genotype is essential. The hypertensio-
genie factors involved, however, have not yet been identified. Guy-
ton et al suggested that abnormal pressure diuresis might produce
hypertension. Thus, a preexisting shift to the right and flattening of
the natriuresis-pressure relationship might elevate the pressure of S
rats exposed to high sodium (Na) intake. To test this hypothesis,
the pressure diuresis of isolated S and R kidneys has been studied
using normotensive donors on a low Na diet. The perfusate was:
albumin (6 g/lOO ml), washed erythrocytes (20%), aminoacids,
vasopressin (5 mU/lOO ml) and aldosterone (25 ng/lOO ml) in
Krebs solution. Perfusion pressure (mm Hg) was increased step-
wise. Natriuresis (UNaV, in FLEq/min/g), GFR (ml/min/g), RBF
(ml/min/g), and fractional Na reabsorption (FRNa, %) were de-
termined. As shown in the table, S and R UNaV were markedly
influenced by the rise in pressure, mainly due to a decrease in
FRNa. However, at similar pressure levels, S and R UNaV were
not statistically different. A shift of the natriuresis-pressure func-
tion was not observed. It is concluded that the preexisting shift
either does not occur or has been abolished under the perfusion
conditions.
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Pressure UNaV OFR RBF FRNa
S kidney 105 0.6 0.2 .49 .02 13.6 :E 1.8 99.7 + 0.2
(N = 5) 125
145
165
1.1 0.5
3.3 0.9
5.8 + 1.9
.48 .06
.55 .05
.59 .13
12.4 + 0.9
12.6 + 0.9
12.9 1.8
98.5 0.5
96.8 :L 1.1
93.2 1.4
R kidney 105 0.5 + 0.1 .43 .06 13.1 :E 0.4 99.2 0.2
(N = 7) 125
145
165
1.7 0.5
3.6 0.7
4.6 + 0.8
.50 + .09
.47 .06
.67 .10
12.9 0.8
12.6 + 0.6
12.7 :E 0.4
97.5 + 0.8
94.2 1.8
95.2 0.9
Effect of acute hypoxemia on renal function iii the rabbit. J. -P.
Guignard, B. Filloux, and E. Gautier. Department of Paediatrics,
CHUV, Lausanne, Switzerland. The effect of acute hypoxemia on
renal function is still controversial. Recent studies in neonates with
respiratory distress syndrome suggested that the observed oliguria
and impaired renal acidification may be related to hypoxemia. To
further define the effect of acute hypoxemia on renal function,
moderate or severe hypoxemia, without changes in plasma pCO2,
were produced in anesthetized rabbits. Moderate hypoxemia (Pa02
= 47.6 4.5 mm Hg) did not significantly change plasma bicarbo-
nate concentration or pCO2. Blood pressure and GFR remained
constant, while PAH clearance decreased significantly from 35.4 to
28.0 mI/mm. In response to hypoxemia, there was also a sharp
significant decrease in urine flow from 0.51 to 0.33 mI/mm, and in
the excretion of sodium, chloride, and bicarbonate. Potassium
excretion and urine pH remained constant. Severe hypoxemia
(PaOz = 31.9 2.7 mmHg) induced a state of moderate metabolic
acidosis. Blood pressure decreased significantly from 104 to 89 mm
Hg. Similarly, inulin and PAH clearances were markedly and
significantly depressed from 8.35 to 5.63 and from 32.5 to 18.8
mI/mm, respectively. There was also a sharp significant decrease in
urine flow and in the excretion of sodium, chloride, and bicarbo-
nate. By constrast, potassium excretion remained constant. In
response to metabolic acidosis, urine pH decreased significantly
from 7.5 to 6.3. It is concluded that acute hypoxemia may induce a
state of renal hypoperfusion, but does not impair urinary acid-
ification.
Antibody-coated bacteria and site of urinary tract infection. B. A.
Gflrtler. Medizinische Universitäts-Poliklinik, Departement für In-
nere Medizin, Kantonsspital, Basel, Switzerland. The distinction
between upper and lower urinary tract infections (UTI) is of great
help for the patient's management and treatment. Thomas et aI
introduced a simple method for the localization of the UTI based
on the demonstration by direct immunofluoresceice of antibodies
complexed with bacteria in the urine. To check the validity of this
method we examined patients with nephrostomies (N = 4), chronic
(N = 3) and acute (N 5) pyelonephritis, cystitis (N = 9) and
permanent indwelling catheters (N = 24). To correlate this tech-
nique with direct localization, we performed 9 bladder washout
procedures in 8 females with indwelling catheters. All 12 patients
with nephrostomies, chronic or acute pyelonephritis, showed
strongly fluorescent-positive bacteria in the urine. Two of the 9
patients diagnosed as having cystitis were positive. Out of 24
patients with indwelling catheters, 17 gave a positive result. The
UTI was localized to the upper urinary tract by the washout
technique in 5 patients and by the immunofluorescence technique
in 7 of 9 patients. The direct immunofluorescence technique
proves to be a simple and reliable method to localize the site of the
UT!. False positive results may occur in patients with indwelling
catheters, possibly due to long standing mechanical irritation, al-
lowing for a more extensive mucosal involvement and probable
coating. Some patients, believed to have cystitis, have in fact an
upper UTI as shown by this technique.
Urinary tract infection and vesico-ureteral reflux after kidney
transplantation. D. Hauri, G. Tomamichel, F. Largiadèr. U. Bin-
swanger. Urologische Klinik. Chirurgische Klinik A und Depart-
ement für Innere Medizin, Nephrologische Station, Kantonsspital
Zirich, Switzerland. Twenty-seven randomly selected recipients of
kidney allografts, 16 men and 11 women, underwent an X-ray
study during micturition four hours after i.v. urography when
pelvis and ureter were emptied from contrast medium. In three
men and three women reflux was observed, two times in the pa-
tients' own ureter, four times in the ureter and the renal pelvis of
the transplant. Concomitant with reflux into the transplant, three
of four patients exhibited repeated urinary tract infection, a com-
plication encountered in only 3 oCthe remaining 23 patients. Both
patients with reflux in their own ureter were not infected. Kidney
function was normal in reflux patients in spite of some slight
alterations of the renal pelvis seen on urography films; no such
changes were found in the group without cystorenal reflux. It can
be concluded that relapsing urinary tract infections in kidney graft
recipients warrant examination for vesicorenal reflux.
Renal handling of calcium in rats: Influence of parathyroid hor-
mone (PTH) and 1 ,25-dihydroxyvitamin D3 (l,25(OH)2D3). K.
Hugi, H. Fleisch, and f-P. Bonjour. Pathophysiologisches Institut,
Universität Bern, Bern, Switzerland. PT!-!: The relationship be-
tween urinary excretion of calcium per ml of glomerular filtrate
(UVCa/ml OF) and plasma calcium concentration ([Ca]P1) was
studied by clearance techniques in thyroparathyroidectomized
(TPTX) rats. [Ca]Pl was varied from 1.5 to 3.5 mM by iv. infusing
of calcium gluconate. Over this range of [Ca]Fl the ultrafiltrable
fraction of plasma calcium remained constant. The changes in
UVCa/ml GF were independent of variations in the fractional
excretion of sodium. At [Ca]Pl, from 1.5 to 3.5 m, there was a
linear increase in UVCa/ml OF corresponding to 35 to 55% of the
increment in filtered load. Infusing PTH at 2.5 lU/hr iv. shifted
the calcium "threshold" from 1.5 to 2.3 msi, but did not change the
slope of the rise of UVCa/ml OF vs. [Ca]Pl. These results are
consistent with two components in the tubular reabsorption of
calcium: a) a saturable process influenced by parathyroid hormone
(PTH) and responsible for the calcium "threshold", and b) a first
order process which would reabsorb 45 to 65% of the filtered load.
I,25(OII)2D3: The relation between UVCa/mI OF and [Ca]Pl was
studied after 1,25-(OH)2D3 supplementation and during supression
of l,25-(OH)2D3 production in vitamin D3-replete rats. In TPTX
rats, the low calcium "threshold" was not corrected by physiologic
doses of l,25-(OH)2D3 (2 X 13 pmoles/day i.p.). Administration of
the diphosphonate EHDP, in doses which inhibited the production
of 1,25-(OH)2D3, did not alter the renal handling of calcium in
both intact and TPTX rats. In conclusion, the kidney does not
appear to alter its tubular handling of calcium in response to
endogenous variation or physiologic supplementation of 1,25-
(OH)2D3 in rats having a normal supply of vitamin D3. This is in
contrast to the marked alteration obtained with PTH.
Comparison of SQ 20881 and saralasin in normotensive and hyper-
tensive rats. P. Jaeger, R. K. Ferguson, H. R. Brunner, and
H. Gavras. Department of Medicine, University of Lausanne, Swit-
zerland. We have further investigated the role of angiotensin in
maintaining the blood pressure (BP) of anesthetized rats. In addi-
tion, we have evaluated the comparative efficacy of two antagonists
of the renin-angiotensin system: SQ 20881 (SQ) inhibits both the
conversion of angiotension I (Al) to angiotensin II (All) and the
inactivation of bradykinin; saralasin (P113) is a competitive antag-
onist of All. In groups of six normal Wistar rats, SQ(l mg/kg i.v.)
lowered BP by 11 1.9mm Hg from a mean of 113mm Hg only
after sodium depletion. Nephrectomized, sodium-depleted animals
had a lower initial BP of 96mm Hg. In this group, however, SQ did
not reduce BP. P113 infusion (5 ng/kg/min) induced a BP effect
identical to that of SQ. Moreover, when administered during P113
infusion, SQ did not reduce BP further. P113 and SQ did not
change BP in spontaneously hypertensive rats (SHR) on normal
sodium intake. Following sodium depletion, P113 reduced BP
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from 158 + 4 to 107 + 5 mm Hg, and SQ produced no additional
effect. When All (200 ng/kg/min) was infused i.v. into normal
rats, SQ did not affect the induced BP increase. In contrast, the BP
increase induced by Al infusion (230 ng/kg/min) was reversed by
P113. Concomitant administration of SQ, however, did not induce
further BP reduction. Conclusions: P113 appears to be equally
effective as SQ in lowering BP, and bradykinin accumulation does
not seem to contribute significantly to the BP-lowering effect of
SQ. Angiotensin inhibition does not reduce BP in nephrectomized
rats, but the BP of young sodium-depleted SHR seems to be
angiotensin-dependent.
Monitoring of pulmonary fluid volume and of stroke volume in
patients on hemodialysis by means of impedance cardiography:
G. Keller and A. Blumberg. Medizinische Klinik, Kanlonsspital,
Aarau, Switzerland. In ten patients with chronic renal failure, basic
thoracic impedance (Z0) was measured at hourly intervals during
hemodialysis treatment by means of an impedance cardiograph
(IFM, MN) and compared to the reduction in body wt (BW).
The increase in Z0 (Z0) varied individually between 1.3 and 5.6
ohms according to HW between —1.3 and —4,0 kg. In the indi-
vidual patients, we found a statistically significant correlation be-
tween Z0 and BW (P < 0.01 to 0.001), between patients, how-
ever, the Z0 values corresponding to a given decrease in BW
differed greatly. Therefore, comparison of sequential measure-
ments is feasible only in one and the same patient. In another
group of eight patients receiving chronic hemodialysis, stroke in-
dex (SI) was calculated according to the method described by
Kubicek et al. Predialysis SI-values varied between 26 and 102
ml/m2 (cardiac index between 1.69 and 5,41 I/minIm2). In sub-
sequent hourly determinations, SI showed a clear tendency to
decrease in three patients, a slight increase was observed in two,
and in the remaining three SI fluctuated around the initial value.
Because the basic thoracic impedance was not constant during
treatment, the calculated changes in SI did not appear to be re-
liable. Moreover, in eight additional patients, SI could not be
determined by impedance cardiography due to the abnormal mor-
phology of the DZ/dt curve, probably resulting from hemody-
namic alterations.
Is there an exudative form of the diabetic glomerulopathy? Dis-
cussion about one case. M. Leski, F. C/zatelanat, and J. C. Mulli.
Hbpital Cantonal, Genève, Switzerland. The discovery of protein-
uria, hematuria and an elevated blood creatinine in an otherwise
healthy 72-yr-old man prompted hospital investigations which
showed: I) mild diabetes (known for six years and treated by diet
and sulfonylureas); 2) moderate arterial hypertension without reti-
nal changes; 3) severe renal insufficiency (blood creatinine, 92
mg/liter); 4) massive proteinuria (6 g/24 hr) without hypoprotei-
nemia; and 5) normal sized kidneys and normal excretory system.
Multiple myeloma was ruled out. Surprisingly, the light micro-
scopic examination did not show any sign of diabetic glomeru-
losclerosis, but disclosed a diffuse proliferative glomerulonephritis
with epithelial crescents. The immunohistologic examination re-
vealed only diffuse linear deposits of IgG along the glomerular
basement membranes together with a faint linear staining for albu-
min, Anti-basement membrane antibodies were not detectable in
the patient's serum. The ultrastructural findings were of dubious
significance. The coincidence of this clinical syndrome with a mi-
crosopic pattern of exsudative glomerulitis and an immunohisto-
logic pattern compatible with diabetic nephropathy made us
consider the very rare diagnosis of diabetic exsudative glom-
erulonephritis.
Recurrent renal lesions in children with kidney transplants. E. P.
Leumann, J. Briner, and F. Largiadèr. Universitäts-Kinderklinik,
Zurich, and Inst it ut far Pathologie and Chirurgische Klinik A, Kan-
tonsspital, Universit'át Zurich. Switzerland. Recurrence of the origi-
nal lesions in the homograft was observed in 4 out of 12 children:
1) in primary hyperoxaluria (PH) (14-yr-old girl); 2) in both pa-
tients with dense deposit disease (DDD) (Il-yr-old girl and 6-yr-
old boy), and 3) in one out of two patients with focal segmental
sclerosis (FSS) (12-yr-old girl). Findings: I) PH.' Although moder-
ate oxalate deposits were found at biopsy three months after trans-
plantation, renal function was still satisfactory after three years
(serum creatinine 1,8 mg/liter. 2) DDD: Slight proteinuria and
hematuria was present in both children. At three years, however,
the nephrotic syndrome appeared in the older patient, and renal
biopsy showed severe recurrence of DDD with focal crescents. 3)
FSS.' Heavy proteinuria was detected during the first week after
transplantation. Biopsy-proven recurrent FSS led to loss of the
graft at ten months; the clinical course was identical to that before
transplantation. FSS did not recur in the second patient, a 14-yr-
old boy, whose original disease lasted ten years. Conclusion: Recur-
rent lesions are an important source of graft failure in children.
Contrary to common belief, the clinical course was better in PH
than anticipated, but more severe in DDD with sufficient follow-
up. Our observations, as well as published and unpublished data,
suggest that recurrrence of FSS is likely to occur if duration of the
original disease is <18 months, but uncommon if duration exceeds
three years.
Silver (Ag) and amphibian epithelia: Interaction with amilo-
ride. J. H. Li and R. C. de Sousa. Dèpartement de Physiologie,
Universitê de Genève, Genève, Switzerland. Previous work from this
laboratory has shown that Ag4- affects permeability properties of
amphibian epithelia. To investigate further its effects on trans-
epithelial sodium transport, we studied the interaction between
Ag and amiloride, a diuretic known as a specific and reversible
blocker of sodium channels in these epithelia. With tissues exposed
to identical sodium sulfate Ringer's solutions, short-circuit current
(SCC) represented sodium net flow. Transepithelial electrical con-
ductance (k) was the sum of active sodium conductance and other
parallel ionic conductances. With Ag4- (104M) in the internal
solution, amiloride (l0-4M) blocked SCC as usual; by contrast, this
blocking action on SCC was markedly reduced from Ca. 100 to 20%
in the presence of Ag4- in the external side. More conspicuously,
Ag4- in the external side induced a "renewed" SCC and an increase
in k in tissues completely blocked by pretreatment with amiloride.
This change in SCC was absent when active sodium extrusion was
first abolished with ouabain, but the change in k persisted. The
effects of Ag added to the external side, however, could be repro-
duced by Ag4- added to the opposite side, when the tissue was made
leaky by increasing the tonicity of the external solution with urea.
These results suggest that Ag4-, although normally unable to tra-
verse the tissue from the inside, could reach, perhaps through
"loosened" tight junctions, the outward-facing membranes of the
tissue and interfere with the action of amiloride. The observed
electrical phenomena could be interpreted on the basis of a simple
equivalent circuit model, but the associated biochemical events and
mechanisms have yet to be identified.
Urinary tract infection in high-risk newborn infants. M. Maherzi and
J.-P. Guignard. Service de Pèdiatrie, CHUV, Lausanne, Switzer-
land. The prevalence of neonatal urinary tract infection (UT!) was
studied in 1,950 infants admitted to the neonatal special care unit
from 1971 to 1974. A significant bacteriuria, established by bladder
puncture, was found in 43 patients (36 boys and 7 girls) (2.2% of
these high-risk neonates). The male preponderance was significant:
3.1% of male infants were affected vs. 0.9% for females. Among
infected patients, 10 were premature, 29 term, and 4 postterm
neonates. The clinical manifestations were extremely variable, and
only 28 of the 43 patients had symptoms suggestive of UT!. Vomit-
ing in 16 patients, jaundice in 16, weight loss and dehydration in
13, and fever in 9 were the prominent symptoms. Other less fre-
quent mainifestations were poor feeding, diarrhea, metabolic acid-
osis, cyanosis and enlarged palpable kidneys. Laboratory in-
vestigations showed the presence of sepsis in 6 patients,
leucocytosis with a marked shift to the left in 14, and thrombocyto-
penia in 6. Isolated indirect hyperbilirubinemia was present in 6.
Leucocyturia was massive in 14 patients, moderate in 11, and
absent in 15. Microscopic hematuria was sometimes observed. The
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organisms identified in the urine were E. coil in 29, klebsiella in 9,
and proteus in I. In the remaining infants, E. coii was associated
with proteus, klebsiella, or enterococcus. Roentgenographic exam-
ination of the urinary tract showed vesicoureteric reflux in 14
infants and a major anatomical abnormality in 2. The significant
frequency of UTI in high-risk neonates and its frequent association
with urinary tract abnormalities warrants routine screening of
these infants for bacteriuria.
Action of thyroxine on sodium transport in toad bladder epithe-
hum. B. C. Rossier, M. Rossier, and C. S. Lo. Ins, itut de Pharma-
cologie de I' Universit& Lausanne, Switzerland, and Department of
Physiology, University of Maryland, Baltimore. Maryland, U.S.A.
The actions of thyroxine (T4) on sodium (Na) transport, mea-
sured by short circuit current (SCC), epithelial cell oxygen con-
sumption (Qoz), and Na-K-ATPase activity, were studied in the
urinary bladder of the toad (Bufo marinus) mounted in Vitro. When
added in Vitro (final concentration, l0 to l0°M), T4 had no
significant effects on SCC, Q02 orNa-K-ATPase activity with up
to 15 hr of incubation. When injected in vivo (- 2zg/l0O g body wt
per day for 6 days), T4 lowered significantly the Na transport
baseline (T4 = 109 13 tA per hemibladder vs. control = 270
42 sA per hemibladder; P < 0.0025). The SCC half-life in the in
Vitro incubation in the absence of T4, however, was significantly
increased by T4 pretreatment in vivo. In addition, T4 did not
increase the cell Qo when expressed per cell DNA but did enhance
it significantly by 6% when expressed perA SCC. (control = 11.3
+ 1.3 pM O2/hrug DNA'LA vs. T4 = 18.7 1.3 pM O2/hr.g
DNA tA; P < 0.01). Finally, T4 had no significant effect on Na-
K-ATPase activity. We conclude that in this poikilotherm spe-
cies, thyroxine apparently does not even partially modulate Qo2 by
regulating Na-K-ATPase activity as has been shown in homeo-
therm species. Thyroxine, however, influences strongly the basal
rate of Na transport in the urinary bladder of the toad, but it is
not yet known whether this represents a direct or indirect action of
the hormone.
Ischemic acute renal failure in the rat. D. de Rougemont, F. P.
Brunner, M. Keller, J. Thorhorst, G. Thiel. Departement für Innere
Medizin, Universität Basel, Switzerland. Acute renal failure was
induced by complete occlusion of the renal artery for 90 mm in the
untouched kidney of previously uninephrectomieed rats. Forty-
eight hours after ischemic injury, the kidneys showed either pre-
dominantly necrotic tubules (group N, N = 10), or predominantly
dilated tubules (group D, N = 9) on histologic examination. Blood
urea had risen to 472 18 in group N and to 294 20 in group D
vs. 39 + S mg/l00 in normal (N = 10) or sham-operated (N = 7)
controls. Proximal tubular pressure (PTP) was measured I to 6 hr,
12 to 20 hr, and 48 hr after releasing the occlusion. At any time
after ischemia, two different nephron populations, dilated trans-
parent tubules and opaque tubules, could be obsrved at the sur-
face of the kidney. PTP in opaque tubules was always low and not
significantly different between the three periods, the mean value
being 8.0 0.3 mm Hg (N = 49). By contrast, PTP was markedly
increased in dilated tubules at Ito 6 hr, averaging 39.0 1.5 (N =
56), and remained elevated at 12 to 20 hr with 19.1 0.7 (N = 48)
and at 48 hr with 20.3 + 0.6 (N = 58). PTP measured 12.4 0.3 (N
= 64) in normal and 12.5 0.3 (N = 78) in sham-operated
controls. (All values mean + sEM.) Conclusions: Ischemic injury is
characterized by two nephron populations: one with elevated tubu-
lar pressure, obviously due to tubular obstruction, and the other
with decreased tubular pressure. One explanation for the low pres-
sure in opaque or necrotic tubules would be leakiness of damaged
tubular walls.
Sites of enzymes involved in 'y-glutamyl cycle along the rat neph-
ron. U. Schmidt, H. Heinle, and A. Wendel. Enzymlabor, Medizi-
nische Poliklinik, Basel, Switzerland, Pathologisrhes Institut und
Biochem. Institut d. Universitât. Thbingen, Gernwny. Amino acids
filtered at the glomerulus are reabsorbed nearly quantitatively
along the proximal convolution. Orlowski and Moister have postu-
lated that the y-glutamyl cycle represents at least a part of the
cellular amino acid reabsorption system in the renal tubule. To
elucidate the possible relation between the reabsorptive process for
amino acids and the y-glutamyl cycle, three of the six enzymes
required for this cycle were determined in single microdissected
tubular segments from the rat kidney: 'y-glutamyltransferase,
glutathione synthetase and 5-oxoprolinase. Glornerulus, proximal
convoluted and straight tubule, and distal convoluted tubule were
dissected from freeze-dried rat kidney slices, weighed, and col-
lected to samples of 200 ng for each assay. The following substrates
were used: -glutamyl-p-nitroanilid for 'y-glutamyltransferase, '4C-
(U)-glutamate and unlabeled cysteine for glutathione synthetase,
and '4C-(U)-5-oxoproline for 5-oxoprolinase. Results: 'y-glutamyl-
transferase and glutathione synthetase were three to fifty times
more active in the proximal straight than in the proximal con-
voluted tubule. 5-oxoprolinase was slightly higher in the proximal
convoluted tubule, compared with the straight portion. The distal
convoluted tubule revealed activity values for all three enzymes
which are comparable to the values found in the proximal con-
volution. The results point out a significant discrepancy between
the site where the 'y-glutamyl cycle is mainly operative and the site
where the bulk of amino acids is reabsorbed within the nephron.
Effect of saralasin on hemodynamics in patients with terminal
renal failure. J. Tuma, R. Beckerhoff, K. Zàruba, J. Furrer, and W.
Vetter. Hämodialyse-Station, Stadtspital Waid Zurich, und Depart-
ement für Innere Medizin der Universitit, Kantonsspital Zirich,
Switzerland. The angiotensin antagonist saralasin was infused (10
g/kg/min for 30 mm) both before and 10 hr after dialysis in ten
hypertensive and four normotensive patients hemodialyzed be-
cause of terminal renal failure. None of the patients had "uncon-
trollable hypertension." A significant increase in mean arterial
pressure (MAP) and total peripheral resistance (TPR) and no
change in cardiac output, measured by impedance cardiography,
were observed during the first few minutes of saralasin infusions,
both before and after dialysis. MAP and TPR decreased during the
second half of the infusion in four hypertensive patients and re-
mained at the preinfusion levels in six hypertensive and four nor-
motensive patients. Plasma renin activity (PRA) was significantly
higher in patients in whom MAP fell both before and after hemo-
dialysis. There was a significant correlation between PRA before
saralasin and the fall in MAP and TPR (r 0.79 and r 0.76, P <
0.001). The initial increase in MAP may be the consequence of
agonistic properties of saralasin. The MAP fall in four of ten
hypertensive patients demonstrates that inadequate high renin and
angiotensin levels are involved in the pathogenesis of hypertension
in some patients with terminal renal failure. Volume factors are
probably of primary importance in the other patients.
Hemodialysis-induced leucopenia: Role of cel]lophane membrane
and complement activation. J. P. Wauters and P. H. Lambert.
Division de Néphrologie et WHO Immunology Center, Dept. de
Médecine, Hbpital Cantonal, Genève, Switzerland. In vitro experi-
ments have suggested that the hemodialysis-induced leucopenia is
related to an activation of the complement system by the cello-
phane membrane of the dialyzer. In this clinical study, WBC
counts, levels of complement components and of complement
breakdown products were followed during dialysis sessions using
either cellophane or polyacrilonitrile membranes. 1) A severe and
transitory leucopenia (from 6.300 to 1.500 WBC/mm3) was ob-
served during the first 15 mm with cellophane membranes; only a
moderate leucopenia (from 5.900 to 4.600 WBC/MM3) occurred
with polyacrilonitrile membranes (P < 0.001). 2) The level of
complement components (CH 50, Clq, C4, C3, factor B, proper-
din) did not change significantly during the first hour of dialysis on
either type of membrane. 3) After one to five hours of dialysis on
cellophane, but not on polyacrilonitrile membranes, there was a
significant increase in the plasma level of breakdown products of
C3 (C3d) and of factor B (Ba). Since no changes were observed
with polyacrilonitrile membranes, contact with cellophane seems
to be responsible for both leucopenia and complement activation.
The early leucopenia, however, is probably not related to the
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complement activation which appears later during the dialysis
session.
Renal function and intrarenal hemodynamics in acutely hypoxic
rats. B. Zillig and B. Truniger. Medizinische Klinik, Kantonsspital,
Luzern, Switzerland. On the basis of microsphere distribution stud-
ies, inert gas washout and standard clearance data, the effects of
acute hypoxia on intrarenal hemodynamics and renal excretory
parameters were studied in anesthetized, mechanically ventilated
rats. Moderate hypoxia (ventilation with 15% 02; mean arterial
P02, 59 mm Hg) caused a brisk increase in diuresis and natriuresis
without changing GFR or filtered sodium load. Due to a decrease
in renal vascular resistance (R) from 46.4 to 36.6 mm Hg
ml' min', mean renal blood flow stayed constant during hypoxia
in spite of a significant drop in mean arterial blood pressure.
Hypoxic changes in renal function and vascular resistance were not
accompanied by significant changes in intrarenal distribution of
blood flow (IDBF). In four animals responding to servere hypoxia
(10% 02; mean Po,, 45 mm Hg) with oliguria/anuria and hypoten-
sion, R was the lowest of all groups (28.8mm Hg ml-' min'). From
these studies we conclude: 1) In the anesthetized rat, acute hypoxia
increases diuresis and natriuresis without changing IDBF, 2) Hy-
poxic renal vasodilation persists even in oliguria and anuria. 3) An
increase in tubular sodium rejection and a systemic blood pressure
insufficient to sustain glomerular filtration are the two principal
opposing mechanisms determining renal excretory function in the
anesthetized, acutely hypoxic rat.
European Dialysis and Transplant Association
Helsinki, Finland
June 1-3, 1977
Peptic ulceration in kidney transplantation. J. Ahonen, B. Ekiund.
0. Lindfors, B. Kuhiback, and B.L. Lindstrim. 4th Departments of
Surgery and Medicine, University Central Hospital of Helsinki,
Finland. The purpose of the paper is to discuss the yet unsolved
problem of gastroduodenal ulceration in connection with clinical
renal transplantation. The problem was clearly evident when the
results of our first 500 transplantations were analyzed. Gastric or
duodenal ulceration was diagnosed in 46 patients during the post-
transplantation period (9%). This was often associated with severe
complications; hemorrhage was seen in 25 patients (pts), per-
foration in 7. Twelve pts with bleeding and all with perforation
died. Of the bleeders, 8 were operated upon; in 5, partial gastric
resection was performed, and 3 died. In three cases, vagotomy was
done; one patient died. These results indicate that despite the fact
that all the pts were on antacids, the morbidity and mortality in
peptic ulceration is unacceptably high. The poor results of treat-
ment of gastroduodenal ulcers stress the need of more effective
prophylactic measures in these pts. Pretransplantation gastric sur-
gery cannot solve the problem, as only 50% of the pts exhibited
dyspeptic symptoms before the transplantation.
Neuromuscular changes after a successful renal transplantation.
R.E. Ahonen and B. Kock. Department of Neurology, University of
Helsinki, and IV Department of Medicine, Helsinki University Cen-
tral Hospital, Helsinki, Finland. The aim of this work has been to
study the neuromuscular system after a successful renal trans-
plantation. Neurologic status and electrophysiologic recordings
were performed on 20 patients. Biopsies of the gastrocnemius
muscle were taken from 10 patients. Muscles were examined histo-
logically, histochemically, and by EM. The average duration of
hemodialysis before transplantation was 13.9 months. Clinical
polyneuropathy was found in 65% and autonomic neuropathy in
30% of the patients. Their symptoms were milder than those of the
hemodialysis patients. The MCV of the posterior tibial nerve was
normal, and the SCV of the sural nerve had significantly risen
compared to that of the hemodialysis patients. The EMG was
pathologic only in 40%, normal in 33%, and showed regenerative
pattern in 27% of the cases. Muscle pathology was found in 80%,
and 50% of the changes were mild. Most of the regenerative find-
ings in neuromuscular system appeared rapidly within two months
A full account of the meeting will appear in the Proceedings of the
EDTA by December, 1977. AB Gambro (Sweden) has kindly
assisted with the publication of the abstracts. Only those abstracts
selected for presentation are included.
after the transplantation. Our results support the view that trans-
plantation is an effective treatment if remarkable recovery from
neuropathy is expected.
Neuromuscular reactions in uremic patients treated with diet ther-
apy and regular hemodialysis program. RE. Ahonen and B. Kock.
Department of Neurology, University of Helsinki, and IV Depart-
ment of Medicine, Helsinki University Central Hospital, Helsinki,
Finland. The reactions of the neuromuscular system and the effects
of treatment in uremia were studied by using clinical examination,
electron physiology, muscle histology, histochemistry, and electron
microscopy. The material consists of 30 patients, 13 of them on
diet therapy and 17 on regular hemodialysis. Clinical poly-
neuropathy was found in 69% and autonomic neuropathy in 31%
of those on diet therapy. The MCV of the posterior tibial nerve was
normal, and the SCV of the sural nerve was significantly lowered.
The EMG was pathologic in 63% of the cases and muscle changes
were found in 50% of the biopsies. Of those on regular hemo-
dialysis, 88% had clinical polyneuropathy and 76% had autonomic
derangement. The MCV was slightly lowered, and the SCV was
significantly lowered. The EMG was pathologic in 60% of the
cases, and extensive pathologic muscle changes were observed in
82% of the muscle biopsies. The results indicate that hemodialysis
affects autonomic nerves and causes extensive muscular changes.
Minimum steroid requirements in renal transplant patients mon-
itored by urinary fibrin degradation products (FDP) andcomplement
(C3). J.L. A nderton, L. Fananapazir, and Maureen Eccleston. Renal
Unit and Department of Medicine, Western General Hospital,
Edinburgh. Scotland, United Kingdom. The purpose of this study
was to define the minimum steroid requirement in patients with
well established renal transplants, monitoring rejection by urinary
FDP and C3 measurements. Urinary FDP and C3 were measured
daily over two years in ten patients who had a renal cadaveric
transplant. Steroid therapy was reduced step-wise over an average
period of fifty weeks to minimum values (range, 5 to 10mg; mean,
7,0 mg of prednisone). Three patients developed rejection when
taking 7.5 mg of prednisone for 10, 21, and 50 weeks, respectively.
In these three patients urinary FDP excretion rose markedly 12, 10,
and 8 weeks, respectively, prior to the diagnosis of rejection and
had fallen to pre-rejection values by the time any significant
changes were observed in renal function. C3 appeared in the urine
of two of the three patients who had graft rejection, heralding the
diagnosis by 14 and 11 days, respectively. The minimal steroid
dosage varied from 0.06 to 0.24 mg of prednisone/kg of body wt
(mean, 0.11), and the three patients who rejected did so on doses of
0.10, 0.13, and 0.16 mg/kg. Doses of prednisone less than 10mg
